 | Up a level |
2021
Chojnacki, K., Lindenblatt, D., Winska, P., Wielechowska, M., Toelzer, C., Niefind, K. and Bretner, M. (2021). Synthesis, biological properties and structural study of new halogenated azolo [4,5-b]pyridines as inhibitors of CK2 kinase. Bioorganic Chem., 106. SAN DIEGO: ACADEMIC PRESS INC ELSEVIER SCIENCE. ISSN 1090-2120
2020
Asif, M., Kaygusuz, E., Shinawi, M., Nickelsen, A., Hochscherf, J., Lindenblatt, D., Noegel, A. A., Tinschert, S., Niefind, K., Fortugno, P., Jose, J., Brancati, F., Nuernberg, P. and Hussain, M. S. (2020). De novo pathogenic variants in CSNK2B cause a new intellectual disability-craniodigital syndrome distinguished from Poirier-Bienvenu neurodevelopmental syndrome. Eur. J. Hum. Genet., 28 (SUPPL 1). S. 129 - 131. LONDON: SPRINGERNATURE. ISSN 1476-5438
2018
Chojnacki, K., Winska, P., Wielechowska, M., Lukowska-Chojnacka, E., Toelzer, C., Niefind, K. and Bretner, M. (2018). Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases. Bioorganic Chem., 80. S. 266 - 276. SAN DIEGO: ACADEMIC PRESS INC ELSEVIER SCIENCE. ISSN 1090-2120
2015
Swider, R., Maslyk, M., Zapico, J. M., Coderch, C., Panchuk, R., Skorokhyd, N., Schnitzler, A., Niefind, K., de Pascual-Teresa, B. and Ramos, A. (2015). Synthesis, biological activity and structural study of new benzotriazole-based protein kinase CK2 inhibitors. RSC Adv., 5 (89). S. 72482 - 72495. CAMBRIDGE: ROYAL SOC CHEMISTRY. ISSN 2046-2069